The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
A sale of the business would have eased the milk processor's debt crisis but further asset sales now on the cards as plunging share price limits scope for capital raise.
Embattled milk processor gets four-month extension on debt repayment deadline as impairments drag half-year loss to $96.2m.
NZX-listed medicinal cannabis firm had earlier this week gone into trading halt amid a shareholder funding dispute.
Chris Kinraid, who has taken up the top job, shares his key focuses as the fashion retailer reports interim earnings.
Despite major shareholder’s withdrawal, Me Today secures investment for growth and research, eyeing global expansion.
The recall follows sound level issues with some of the devices, which deliver high flow air therapy to patients.
Halt pending outcome of talks with its banking syndicate on $130 million of debt repayments due today.
From a $73m loss in FY22 to $28.5m profit for FY24, NZ King Salmon reckons its strategic farming practices are working.
The council wants to reduce its shareholding in the Bluff-based port from 66% to 51% to diversify its investment income.